Quick Answer
BioRestorative Therapies, Inc. reported Earnings Per Share Diluted of $1.58 (loss) per share for the year ending 2025.
- BioRestorative Therapies, Inc. showed a decrease of -36.2% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from BioRestorative Therapies, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2019: $0.24 (loss) per share | Q2 2020: $0.00 per share | Q2 2022: $1.28 (loss) per share | Q3 2022: $1.28 (loss) per share | Q1 2023: $1.93 (loss) per share | Q2 2023: $1.47 (loss) per share | Q3 2023: $0.39 per share | Q1 2024: $0.33 (loss) per share | Q2 2024: $0.50 (loss) per share | Q3 2024: $0.13 (loss) per share | Q1 2025: $0.64 (loss) per share | Q2 2025: $0.30 (loss) per share | Q3 2025: $0.33 (loss) per share.
- Over the full 4 years of available data (2022 to 2025), BioRestorative Therapies, Inc.'s Earnings Per Share Diluted has grown by 69.1%.
- Historical annual values: Fiscal year 2025: $1.58 (loss) per share | Fiscal year 2024: $1.16 (loss) per share | Fiscal year 2023: $2.47 (loss) per share | Fiscal year 2022: $5.11 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: